Raia Drogasil (RADLY) Stock Price, News & Analysis

Company Overview

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Key Stats

• Today's Range: $2.30 to $2.83
• 50-Day Range: $2.22 to $3.46
• 52-Week Range: $2.21 to $14.00
• Volume: 675 shs
• Average Volume: 4,863 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RADLY Stock Analysis - Frequently Asked Questions

How have RADLY shares performed this year?

Raia Drogasil's stock was trading at $3.25 at the beginning of the year. Since then, RADLY shares have decreased by 29.2% and is now trading at $2.30.

When did Raia Drogasil's stock split?

Raia Drogasil shares split on the morning of Monday, May 22nd 2023.The 26-25 split was announced on Monday, May 22nd 2023. The newly minted shares were issued to shareholders after the market closes on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split.

How do I buy shares of Raia Drogasil?

Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Record date for 6/9 Dividend: 12/12/2024
• Ex-Dividend for 6/9 Dividend: 12/12/2024
• Dividend Payable: 6/09/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/05/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RADLY
• CIK: N/A
• Web: www.rd.com.br
• Phone: 551137695678
• Fax: N/A
• Employees: 57,708
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A